Literature DB >> 11939679

National Pharmacy Cardiovascular Council treatment guidelines for the management of type 2 diabetes mellitus: toward better patient outcomes and new roles for pharmacists.

David Hawkins1, J Chris Bradberry, Mark J Cziraky, Robert L Talbert, David W Bartels, Joli D Cerveny.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11939679     DOI： 10.1592/phco.22.7.436.33667

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN： 0277-0008            Impact factor:   4.705


× No keyword cloud information.
  5 in total

1.  Retrospective examination of selected outcomes of Medicines Use Review (MUR) services in New Zealand.

Authors:  Ernieda Hatah; June Tordoff; Stephen B Duffull; Claire Cameron; Rhiannon Braund
Journal:  Int J Clin Pharm       Date:  2014-03-15

Review 2.  Rosiglitazone/Metformin.

Authors:  Keri Wellington
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Impact of pharmaceutical care on quality of life in patients with type 2 diabetes mellitus.

Authors:  Shanmugam Sriram; Lini Elizabeth Chack; Rajeswari Ramasamy; Ali Ghasemi; Thengungal Kochupapy Ravi; Ali Mohammad Sabzghabaee
Journal:  J Res Med Sci       Date:  2011-03       Impact factor: 1.852

4.  The association between diabetes related medical costs and glycemic control: a retrospective analysis.

Authors:  Alan K Oglesby; Kristina Secnik; John Barron; Ibrahim Al-Zakwani; Maureen J Lage
Journal:  Cost Eff Resour Alloc       Date:  2006-01-16

5.  Association between restrictive pulmonary disease and type 2 diabetes in Koreans: A cross-sectional study.

Authors:  Do Y Lee; Seung M Nam
Journal:  World J Diabetes       Date:  2020-10-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.